SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-014594
Filing Date
2023-05-15
Accepted
2023-05-15 16:23:35
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20230331_10q.htm   iXBRL 10-Q 862590
2 EXHIBIT 31.1 ex_500177.htm EX-31.1 15827
3 EXHIBIT 31.2 ex_500178.htm EX-31.2 15381
4 EXHIBIT 32.1 ex_500179.htm EX-32.1 8611
  Complete submission text file 0001437749-23-014594.txt   4521675

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wint-20230331.xsd EX-101.SCH 43166
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20230331_cal.xml EX-101.CAL 24475
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20230331_def.xml EX-101.DEF 341683
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20230331_lab.xml EX-101.LAB 271335
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20230331_pre.xml EX-101.PRE 355988
48 EXTRACTED XBRL INSTANCE DOCUMENT wint20230331_10q_htm.xml XML 541088
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39290 | Film No.: 23922900
SIC: 2836 Biological Products, (No Diagnostic Substances)